|
Session 121
Poster Abstracts
Pharmacokinetics of Antiretroviral Drugs in Pregnant Women and Infants
Monday, 1:30 - 3:30 pm
Poster Hall |
| 707 |
Nelfinavir Plasma Concentrations in 40 Pregnant Women
Marie-Aude Khuong-Josses*1, A Boussaïri1, M Herida2, S Abbas1, and D Méchali1
1Hosp Delafontaine, St Denis, France and 2Inst Veille Sanitaire, Saint Maurice, France |
708
 |
Pharmacokinetics and Safety of Tenofovir Disoproxil Fumarate in HIV-1-infected Pregnant Women and their Infants
John Rodman*1, P Flynn1, D Shapiro2, A Bardeguez3, S Huang4, S Fiscus5, V Koen6, J Rooney7, L Mofenson8, J P Patrick9, and PACTG 394 Study Team
1St Jude Children's Res Hosp, Memphis, TN, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Univ of Med and Dentistry of New Jersey, Newark, US; 4Statistical and Data Analysis Ctr, Boston, MA, US; 5Univ of North Carolina at Chapel Hill, US; 6Univ of California, Davis, US; 7Gilead Sci, Foster City, CA, US; 8Natl Inst Child Hlth and Devt, NIH, DHHS, Bethesda, MD, US; and 9Div of AIDS, NIAID, NIH, DHHS, Bethesda, MD, US |
| 709 |
Adequate Trough Lopinavir Levels with Standard Dosing in Pregnancy
Fiona Lyons*, M Lechelt, V Magaya, R Issa, and A Deruiter
St Thomas' Hosp, London, UK |
710
|
Adequate Lopinavir Exposure Achieved with a Higher Dose during the Third Trimester of Pregnancy
Mark Mirochnick*1, A Stek2, E Capparelli3, B Best3, D Holland3, J Connor3, S Burchett4, C Hu5, E Smith6, J Read7, and PACTG 1026s Protocol Team
1Boston Univ Sch of Publ Hlth, MA, US; 2David Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, US; 3Univ of California, San Diego, US; 4Children’s Hosp, Boston, MA, US; 5Harvard Sch of Publ Hlth, Boston, MA, US; 6NIAID, NIH, DHHS, Bethesda, MD, US; and 7Natl Inst Child Hlth and Devt, NIH, DHHS, Bethesda, MD, US |
|
